1.38BMarket Cap-7318P/E (TTM)
21.525High20.640Low269.22KVolume20.820Open20.780Pre Close5.69MTurnover0.49%Turnover RatioLossP/E (Static)64.41MShares24.37752wk High3.71P/B1.17BFloat Cap4.22052wk Low--Dividend TTM54.75MShs Float52.380Historical High--Div YieldTTM4.26%Amplitude4.220Historical Low21.127Avg Price1Lot Size
Nurix Therapeutics Stock Forum
as this guy 👇
$Taysha Gene Therapies(TSHA.US)$ 21% FY 2023 results
$TFF Pharmaceuticals(TFFP.US)$ 14% Clinical programs update
$Jaguar Health(JAGX.US)$ 14% Crofelemer commercialization
$Acelyrin(SLRN.US)$ 4% Ph1/2 positive data
$Delcath Systems(DCTH.US)$ 3% Closes $7M private placement
$Sellas Life Sciences(SLS.US)$ 0% Closes $20M offering & private placement
$Immunic(IMUX.US)$ 1% Patent notice of allowance
$Nurix Therapeutics(NRIX.US)$ 0...
Nurix said patients currently enrolled in the trial who are deriving clinical benefit are allowed to continue receiving the current drug product. The screening and enrollment of new patients has been paused.
The company sai...
No comment yet